This is a serious condition that affects very young babies, especially those born too early or who are sick. It causes the skin under their skin to become hard, cold, and yellowish. It can be life-threatening.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Sclerema of the newborn, also called sclerema neonatorum, is a rare and serious condition in which the layer of fat beneath a baby's skin becomes hard. The skin turns cold, smooth, firm and waxy, and it may look pale, mottled or purplish. Because the hardened skin is bound down to the muscle and bone beneath it, it cannot be pinched into a fold or dented with a fingertip, and the baby's arms and legs may become stiff. The hardening usually starts on the buttocks, thighs or trunk and can spread quickly over much of the body, typically sparing the palms, soles and genitals. As the skin tightens, it can make breathing and feeding harder. Sclerema almost always appears in babies who are already very ill, most often premature babies in their first week of life, although it can develop weeks or months after birth. It is now seen rarely in places with modern newborn intensive care. Two other newborn skin conditions can look similar but behave very differently. Subcutaneous fat necrosis of the newborn causes firm, movable lumps, usually in an otherwise healthy full-term baby, and scleredema causes firm skin with swelling that does dent when pressed. Both usually clear up on their own.
The exact cause of sclerema is not known. Researchers have proposed that it may involve differences in the makeup or handling of fat in newborns, or that it is a sign of how severely ill a baby has become, but none of these explanations is settled. What is clear is the setting in which it appears. Most affected babies are premature and have a serious underlying illness, most commonly sepsis (a bloodstream infection that overwhelms the body). Other associated problems include birth defects such as congenital heart disease, breathing and digestive illnesses, low body temperature, dehydration from severe diarrhea, and poor nutrition. In one hospital study of premature babies, poor feeding and jaundice (yellowing of the skin) often came before the skin hardened. These are associations seen in very sick infants, not something parents caused.
Doctors usually recognize sclerema by examining the baby. The key features are widespread, cold, hard skin that cannot be pinched up or dented, its pattern on the body, and the fact that it appears in a baby who is already seriously ill. A small skin sample (biopsy), examined under a microscope, can confirm the diagnosis. It is mainly useful when the picture is unclear, because it separates sclerema from subcutaneous fat necrosis and scleredema, which usually resolve without specific treatment. Alongside the skin assessment, the care team looks hard for the underlying illness. That typically means blood tests and cultures to check for infection, and other tests depending on the baby's condition.
There are no established treatment guidelines for sclerema, and no treatment has been proven in large trials to reverse it. Care takes place in a newborn intensive care unit and focuses on the underlying illness and on supporting the baby's body while it recovers. Intravenous antibiotics are started promptly when infection is suspected, because sepsis is so often present. Supportive care includes careful warming and temperature control, correcting fluids and body salts, breathing support with oxygen or a ventilator when needed, and nutrition. Some additional treatments have been tried. Exchange transfusion, in which a baby's blood is gradually replaced with donor blood, was linked to better survival in one small trial of 40 newborns with sepsis and sclerema (half of treated babies died, compared with nearly all of those who did not receive it), but the evidence is limited and the procedure is used less often today. Steroid medicines and intravenous immunoglobulin (concentrated antibodies from donated blood) have been reported in individual cases with mixed results. Support for parents is a recognized part of care.
Sclerema is a very serious sign. Older reviews and studies, many from settings with limited intensive care, report that most affected babies died, with fatality rates often above 80 percent and ranging widely. A study of older infants with sclerema and diarrhea found lower but still substantial mortality, and babies who developed septic shock (dangerously low blood pressure from infection) were at greatest risk. These figures come from small groups, and outcomes in modern intensive care units have not been well measured. The outlook depends largely on the underlying illness and how well it responds to treatment. Some babies, particularly full-term babies whose sclerema began later, have survived with supportive care, and in reports of survivors the skin softened gradually over months. Lasting skin problems have not been reported in babies who recover. For parents, the hospital stay can be long and uncertain, and regular conversations with the care team about how the baby is responding are part of the process.
Most babies with sclerema are already in hospital. If your baby is in intensive care and you notice the skin becoming harder, colder or tighter, or your baby seems less responsive, tell the nurses or doctors right away. At home, a baby younger than three months who feels unusually cold or has a fever, feeds poorly or stops sucking well, moves much less than usual, has trouble breathing, or develops cold, hard, tight skin needs emergency medical care right away, because these can be signs of a serious infection.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Sclerema of the Newborn is like, what's helped you, or ask the community a question.